Published in J Bacteriol on May 01, 1993
Arac/XylS family of transcriptional regulators. Microbiol Mol Biol Rev (1997) 6.56
The TetR family of transcriptional repressors. Microbiol Mol Biol Rev (2005) 6.02
Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev (2000) 5.21
Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Chemother (1997) 4.40
Linkage map of Escherichia coli K-12, edition 10: the traditional map. Microbiol Mol Biol Rev (1998) 4.18
Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway. J Bacteriol (1993) 3.95
Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. J Bacteriol (1997) 3.81
Repressor mutations in the marRAB operon that activate oxidative stress genes and multiple antibiotic resistance in Escherichia coli. J Bacteriol (1994) 3.13
Binding of purified multiple antibiotic-resistance repressor protein (MarR) to mar operator sequences. Proc Natl Acad Sci U S A (1995) 3.09
Regulation of bacterial drug export systems. Microbiol Mol Biol Rev (2002) 3.00
EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB. J Bacteriol (1995) 2.99
Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli. J Bacteriol (1995) 2.55
Activation of multiple antibiotic resistance and binding of stress-inducible promoters by Escherichia coli Rob protein. J Bacteriol (1995) 2.53
Overexpression of the robA gene increases organic solvent tolerance and multiple antibiotic and heavy metal ion resistance in Escherichia coli. Appl Environ Microbiol (1995) 2.18
Dual regulation of inaA by the multiple antibiotic resistance (mar) and superoxide (soxRS) stress response systems of Escherichia coli. J Bacteriol (1994) 2.16
Autoactivation of the marRAB multiple antibiotic resistance operon by the MarA transcriptional activator in Escherichia coli. J Bacteriol (1996) 2.07
Organic solvent tolerance and antibiotic resistance increased by overexpression of marA in Escherichia coli. Appl Environ Microbiol (1997) 1.98
Genetic relationship between soxRS and mar loci in promoting multiple antibiotic resistance in Escherichia coli. Antimicrob Agents Chemother (1994) 1.98
Transcriptional activation of promoters of the superoxide and multiple antibiotic resistance regulons by Rob, a binding protein of the Escherichia coli origin of chromosomal replication. J Bacteriol (1996) 1.96
Purification and regulatory properties of MarA protein, a transcriptional activator of Escherichia coli multiple antibiotic and superoxide resistance promoters. J Bacteriol (1995) 1.95
The Salmonella typhimurium mar locus: molecular and genetic analyses and assessment of its role in virulence. J Bacteriol (1997) 1.91
Identification of new genes regulated by the marRAB operon in Escherichia coli. J Bacteriol (1995) 1.75
Antibiotic stress, genetic response and altered permeability of E. coli. PLoS One (2007) 1.50
Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones. Antimicrob Agents Chemother (1996) 1.49
Isolation and characterization of a gene, pmrD, from Salmonella typhimurium that confers resistance to polymyxin when expressed in multiple copies. J Bacteriol (1994) 1.37
Genetic definition of the Escherichia coli zwf "soxbox," the DNA binding site for SoxS-mediated induction of glucose 6-phosphate dehydrogenase in response to superoxide. J Bacteriol (1995) 1.34
Analysis of the genetic requirements for inducible multiple-antibiotic resistance associated with the mar locus in Escherichia coli. J Bacteriol (1994) 1.32
The transcriptional regulator SoxS is required for resistance of Salmonella typhimurium to paraquat but not for virulence in mice. Infect Immun (1997) 1.31
Characterization of aarA, a pleiotrophic negative regulator of the 2'-N-acetyltransferase in Providencia stuartii. J Bacteriol (1994) 1.30
Pediatric fecal microbiota harbor diverse and novel antibiotic resistance genes. PLoS One (2013) 1.27
Chromosomal tetA(L) gene of Bacillus subtilis: regulation of expression and physiology of a tetA(L) deletion strain. J Bacteriol (1996) 1.27
Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains. Antimicrob Agents Chemother (2003) 1.26
Expression of Escherichia coli TehA gives resistance to antiseptics and disinfectants similar to that conferred by multidrug resistance efflux pumps. Antimicrob Agents Chemother (1997) 1.24
mar Operon involved in multidrug resistance of Enterobacter aerogenes. Antimicrob Agents Chemother (2002) 1.23
Fis, an accessorial factor for transcriptional activation of the mar (multiple antibiotic resistance) promoter of Escherichia coli in the presence of the activator MarA, SoxS, or Rob. J Bacteriol (1997) 1.22
Regulation of the multiple antibiotic resistance (mar) regulon by marORA sequences in Escherichia coli. J Bacteriol (1995) 1.21
Multiple antibiotic resistance (mar) locus in Salmonella enterica serovar typhimurium DT104. Appl Environ Microbiol (2001) 1.18
Identification and analysis of aarP, a transcriptional activator of the 2'-N-acetyltransferase in Providencia stuartii. J Bacteriol (1995) 1.17
Inhibition of the multiple antibiotic resistance (mar) operon in Escherichia coli by antisense DNA analogs. Antimicrob Agents Chemother (1997) 1.03
Cloning of multidrug resistance gene pqrA from Proteus vulgaris. Antimicrob Agents Chemother (1995) 0.99
The periplasmic murein peptide-binding protein MppA is a negative regulator of multiple antibiotic resistance in Escherichia coli. J Bacteriol (1999) 0.97
A rob-like gene of Enterobacter cloacae affecting porin synthesis and susceptibility to multiple antibiotics. Antimicrob Agents Chemother (1996) 0.90
MarA, SoxS and Rob of Escherichia coli - Global regulators of multidrug resistance, virulence and stress response. Int J Biotechnol Wellness Ind (2013) 0.87
Activation of the 2'-N-acetyltransferase gene [aac(2')-Ia] in Providencia stuartii by an interaction of AarP with the promoter region. Antimicrob Agents Chemother (1999) 0.80
Gene Expression during Survival of Escherichia coli O157:H7 in Soil and Water. Int J Microbiol (2010) 0.80
Activation of multiple antibiotic resistance in uropathogenic Escherichia coli strains by aryloxoalcanoic acid compounds. Antimicrob Agents Chemother (2001) 0.79
AraC/XylS family stress response regulators Rob, SoxS, PliA, and OpiA in the fire blight pathogen Erwinia amylovora. J Bacteriol (2014) 0.75
Dissecting the expression patterns of transcription factors across conditions using an integrated network-based approach. Nucleic Acids Res (2010) 0.75
Strand-specific transcriptomes of Enterohemorrhagic Escherichia coli in response to interactions with ground beef microbiota: interactions between microorganisms in raw meat. BMC Genomics (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene (1977) 114.87
The physical map of the whole E. coli chromosome: application of a new strategy for rapid analysis and sorting of a large genomic library. Cell (1987) 46.35
New method for generating deletions and gene replacements in Escherichia coli. J Bacteriol (1989) 12.66
One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc Natl Acad Sci U S A (1989) 11.49
A unique mechanism regulating gene expression: translational inhibition by a complementary RNA transcript (micRNA). Proc Natl Acad Sci U S A (1984) 8.67
Uses of transposons with emphasis on Tn10. Methods Enzymol (1991) 8.13
The ompB locus and the regulation of the major outer membrane porin proteins of Escherichia coli K12. J Mol Biol (1981) 7.69
Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. J Bacteriol (1983) 7.06
The helix-turn-helix DNA binding motif. J Biol Chem (1989) 6.87
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob Agents Chemother (1984) 6.81
Positive control of a global antioxidant defense regulon activated by superoxide-generating agents in Escherichia coli. Proc Natl Acad Sci U S A (1990) 6.05
Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli. J Bacteriol (1993) 6.02
In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid. Antimicrob Agents Chemother (1983) 5.45
Endonuclease IV (nfo) mutant of Escherichia coli. J Bacteriol (1986) 5.32
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother (1989) 5.09
marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J Bacteriol (1988) 4.97
Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia. J Infect Dis (1985) 4.52
Molecular characterization of the soxRS genes of Escherichia coli: two genes control a superoxide stress regulon. Nucleic Acids Res (1991) 4.50
Gene in the major cotransduction gap of the Escherichia coli K-12 linkage map required for the expression of chromosomal resistance to tetracycline and other antibiotics. J Bacteriol (1983) 4.37
marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli. J Bacteriol (1991) 3.83
Activation of oxidative stress genes by mutations at the soxQ/cfxB/marA locus of Escherichia coli. J Bacteriol (1991) 3.75
The terminus region of the Escherichia coli chromosome contains two separate loci that exhibit polar inhibition of replication. Proc Natl Acad Sci U S A (1987) 3.26
Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation. Antimicrob Agents Chemother (1989) 2.99
Construction and characterization of a deletion mutant lacking micF, a proposed regulatory gene for OmpF synthesis in Escherichia coli. J Bacteriol (1985) 2.77
Cloning and expression of the Escherichia coli K-12 sad gene. J Bacteriol (1988) 0.96
Suppression of ribosomal reinitiation at upstream open reading frames in amino acid-starved cells forms the basis for GCN4 translational control. Mol Cell Biol (1991) 3.83
Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev (1987) 3.31
Requirements for intercistronic distance and level of eukaryotic initiation factor 2 activity in reinitiation on GCN4 mRNA vary with the downstream cistron. Mol Cell Biol (1994) 2.17
Genetic relationship between soxRS and mar loci in promoting multiple antibiotic resistance in Escherichia coli. Antimicrob Agents Chemother (1994) 1.98
The Salmonella typhimurium mar locus: molecular and genetic analyses and assessment of its role in virulence. J Bacteriol (1997) 1.91
Sequences 5' of the first upstream open reading frame in GCN4 mRNA are required for efficient translational reinitiation. Nucleic Acids Res (1995) 1.66
The synthesis, structure-activity, and structure-side effect relationships of a series of 8-alkoxy- and 5-amino-8-alkoxyquinolone antibacterial agents. J Med Chem (1995) 1.49
Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7. J Med Chem (1996) 1.48
Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position. Antimicrob Agents Chemother (1996) 1.46
A quantitative model for translational control of the GCN4 gene of Saccharomyces cerevisiae. New Biol (1991) 1.33
Analysis of the genetic requirements for inducible multiple-antibiotic resistance associated with the mar locus in Escherichia coli. J Bacteriol (1994) 1.32
Functional and biochemical characterization of Escherichia coli sugar efflux transporters. J Biol Chem (1999) 1.29
The first and fourth upstream open reading frames in GCN4 mRNA have similar initiation efficiencies but respond differently in translational control to change in length and sequence. Mol Cell Biol (1988) 1.28
In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin. J Antimicrob Chemother (1997) 1.27
Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial. Aliment Pharmacol Ther (1992) 1.18
The lethal multiple congenital anomaly syndrome of polydactyly, sex reversal, renal hypoplasia, and unilobular lungs. J Med Genet (1986) 1.15
The identification of a new family of sugar efflux pumps in Escherichia coli. Mol Microbiol (1999) 1.10
Effect of lipophilicity at N-1 on activity of fluoroquinolones against mycobacteria. J Med Chem (1995) 0.99
5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV protease. J Med Chem (2000) 0.88
Synthesis of 5,6-dihydro-4-hydroxy-2-pyrones as HIV-1 protease inhibitors: the profound effect of polarity on antiviral activity. J Med Chem (1997) 0.88
4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV protease. J Med Chem (1997) 0.87
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitor. Bioorg Med Chem (1999) 0.80
Compounds that target novel cellular components involved in HIV-1 transcription. Mol Med (1995) 0.80
Selenium status in relation to reduced glutathione peroxidase activity in aspirin-sensitive asthma. Clin Exp Allergy (1991) 0.79
Emergency coronary angioplasty for acute myocardial infarction. Results from a community hospital. Arch Intern Med (1987) 0.79
4-Hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: the effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parameters. J Med Chem (2001) 0.78
Factors that predict improvement in left ventricular ejection fraction after coronary angioplasty for acute myocardial infarction. Cathet Cardiovasc Diagn (1988) 0.78
Limitations of the DNS assay for reducing sugars from saccharified lignocellulosics. Biotechnol Bioeng (1984) 0.78
Long term prognosis of recurrent haematuria. Arch Dis Child (1985) 0.77
Stepwise approaches for estimating the intakes of chemicals in food. Regul Toxicol Pharmacol (1997) 0.77
Synthesis and antibacterial activity of new quinolones containing a 7-[3-(1-amino-1-methylethyl)-1-pyrrolidinyl] moiety. Gram-positive agents with excellent oral activity and low side-effect potential. J Med Chem (1994) 0.75
Remedies for Common Cold Symptoms: Making sense of myriad drugs. Can Fam Physician (1991) 0.75
Blood testing compared with urine testing in the long term control of diabetes. Arch Dis Child (1983) 0.75
Immunoregulatory treatment for minimal change nephrotic syndrome. Arch Dis Child (1986) 0.75
Multi-element survey of wild edible fungi and blackberries in the UK. Food Addit Contam (2006) 0.75
Etidronate and alendronate in the treatment of postmenopausal osteoporosis. Ann Pharmacother (1999) 0.75
Small-bowel obstruction from bran cereal. JAMA (1990) 0.75
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl,5-methylphenyl thio) moiety: antiviral activities and pharmacokinetic properties. Bioorg Med Chem Lett (1999) 0.75
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing a novel and achiral 3-(2-t-butyl-5-methyl-4-sulfamate)phenylthio moiety. Bioorg Med Chem Lett (1999) 0.75
Human selenium status and glutathione peroxidase activity in north-west England. Eur J Clin Nutr (1990) 0.75
Nonpeptidic HIV protease inhibitors: 4-hydroxy-pyran-2-one inhibitors with functional tethers to P1 phenyl ring to reach S3 pocket of the enzyme. Biochem Biophys Res Commun (1996) 0.75
Nutritional considerations in a patient with gastroparesis. Diabetes Educ (1989) 0.75
2,2'-Dithiobisbenzamides derived from alpha-, beta- and gamma-amino acids possessing anti-HIV activities: synthesis and structure-activity relationship. Bioorg Med Chem (1998) 0.75
What every diabetes educator needs to know about hypoglycemia. Diabetes Educ (1989) 0.75